medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 615

<< Back Next >>

Rev Med Cos Cen 2015; 72 (615)

Manejo y costos de los pacientes hipertensos del área de salud de Guácimo

Salas GM, Rivera DV

Language: Spanish
References: 29
Page: 293-301
PDF size: 506.19 Kb.


ABSTRACT

Backgrounds: I made a study observational, transversal, to know the handling the hypertensive patient for their diagnosis until now period, and impact economic of this pathology in the social security. Methods: The population count until September 31st 2011 in the Health Area of Guacimo is 3445 patients. I reviewed 577 records, in order to analyze age, genre, weight, smoking, blood pressure, the year of diagnosis, class and quantity antihypertensive therapy, complications, associated diseases (obesity, dislipidemia and diabetes mellitus) and some laboratory exams. Results: The populations to enroll are 541 patients, the ratio womenmen 2:1, the blood pressure average was 130/78mmHg. On regards the risk factor, 63% men are older than 55 years and 25% women older than 65 years, smoking 9%, 45% had glucose high or equal of 100mg/dl, 47%, diabetics 33% and whit dislipidemia 39%. Conclusion: Less than half of patients to carry out with the hypertensive goal. The principal complications are the renal failure and left ventricular hypertrophy. The obesity is the associated diseases more frequently. On regards annual cost in drugs and laboratory for a one patient is 13 509.92 colons.


REFERENCES

  1. ACCF/AHA/AMA–PCPI 2011 Performance Measures for Adults With Coronary Artery Disease and Hypertension 2011.

  2. Aggarwal M, Khan IA. Hypertensive Crisis: Hypertensive Emergencies and Urgencies. M Cardiol Clin 24 (2006) 135–146.

  3. Bertoia ML, Waring ME, Gupta PS, Roberts MB, Eaton CB. Implications of New Hypertension Guidelines in the United States. Hypertension. 2011;58:361-366.

  4. Caja Costarricense de Seguro Social. Guías para la detección, diagnóstico y tratamiento de la Hipertensión arterial. 2009.

  5. Chrysant SG and Chrysant GS. Effectiveness of Lowering Blood Pressure to Prevent Stroke Versus to Prevent Coronary Events. Am J Cardiol 2010;106:825–829.

  6. Chow C, Jolly S, Rao-Melacini P, Fox K, Anand S, Yusuf S. Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes. Circulation. 2010; 121:750-758.

  7. European Society of Hypertension and of the European Society of Cardiology. Guidelines for the Management of Arterial Hypertension. Journal of Hypertension. 2007, 25:1105–1187.

  8. Frohlich ED. Current Challenges and Unresolved Problems in Hypertensive Disease. Med Clin N Am 93 (2009) 527–540.

  9. Guan Z, Inscho EW. Role of Adenosine 5`-Triphosphate in Regulating Renal Microvascular Function and in Hypertension. Hypertension. 2011;58:333-340.

  10. Hebert CJ, Vidt DG. Hypertensive Crises. Prim Care Clin Office Pract; 35 (2008) 475–487.

  11. INEC, Unidad de Información estadística y Ministerio de Salud, Dirección de Vigilancia en Salud. Mortalidad 2010.

  12. Jain A, Tandri H, Dalal D, Chahal H, Soliman EZ, Prineas RJ, et al. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 2010;159:652-8.

  13. Joint National Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. 2004.

  14. Kaplan NM, Opie LH. Controversies in Cardiology 2, Controversies in hypertension. Lancet 2006; 367: 168– 76.

  15. Kavey R W, Daniels SR, Flynn JT. Management of High Blood Pressure in Children and Adolescents. Cardiol Clin 28 (2010) 597–607.

  16. Khosla N, Kalaitzidis R, Bakris GL. The Kidney, Hypertension, and Remaining Challenges. Med Clin N Am 93 (2009) 697–715.

  17. Mensah GA, Bakris G. Treatment and Control of High Blood Pressure in Adults. Cardiol Clin 28 (2010) 609– 622.

  18. Murphy BP, Stanton T, Dunn FG. Hypertension and Myocardial Ischemia. Med Clin N Am 93 (2009) 681–695.

  19. National Clinical Guideline Centre. Hypertension: The clinical management of primary hypertension in adults. 2011.

  20. Padiyar A. Nonpharmacologic Management of Hypertension in the Elderly. Clin Geriatr Med 25 (2009) 213–219.

  21. Quesada O. ASH 2009, hipertensión arterial y el riñón y hipertensión arterial y diabetes mellitus. Acta medica periódica Octubre 2009; Número 101: 1-11.

  22. Rashidi A, Wright JT. Drug Treatment of Hypertension in Older Hypertensives. Clin Geriatr Med 25 (2009) 235–244.

  23. Ram VS. Beta-Blockers in Hypertension. Am J Cardiol 2010;106:1819–1825.

  24. Stewart DL, Feinstein SE, Colgan R. Hypertensive Urgencies and Emergencies. Prim Care Clin Office Pract 33 (2006) 613–623.

  25. Suzuki T, Homma S. Treatment of Hypertension and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome. Med Clin N Am 91 (2007) 1211–1223.

  26. Taler SJ. Secondary Causes of Hypertension. Prim Care Clin Office Pract. 35 (2008) 489–500.

  27. The Society of Obstetricians and Gynaecologists of Canada. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy. Journal of Obstetrics and Gynaecology Canada 2008.

  28. Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52.

  29. Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of Antihypertensive Agents on Blood Pressure Variability: The Natrilix SR Versus Candesartan and Amlodipine in the Reduction of Systolic Blood Pressure in Hypertensive Patients (X-CELLENT) Study. Hypertension. 2011;58:155- 160.




2020     |     www.medigraphic.com